全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

恶性梗阻性黄疸ERCP术后并发症危险因素
Malignant Obstructive Jaundice ERCP Postoperative Complications Risk Factors

DOI: 10.12677/acrem.2024.124024, PP. 153-158

Keywords: 恶性梗阻性黄疸,经内镜逆行性胰胆管造影,胆道感染,ERCP术后胰腺炎,穿孔,出血,危险因素
Malignant Obstructive Jaundice
, Endoscopic Retrograde Cholangiopancreatography, Biliary Tract Infection, Post-ERCP Pancreatitis, Perforation, Hemorrhage, Risk Factors

Full-Text   Cite this paper   Add to My Lib

Abstract:

恶性梗阻性黄疸是一种常见且严重的临床状况,内窥镜逆行胰胆管造影(ERCP)作为其重要的治疗手段,虽然具有较高的成功率,但术后并发症的发生率仍然较为显著。本文综述了恶性梗阻性黄疸患者在ERCP术后可能面临的并发症及其相关危险因素,并探讨其发生机制及处理措施,旨在为临床医生提供对恶性梗阻性黄疸患者ERCP的风险评估及管理策略,以改善患者的术后预后并减少并发症的发生。
Malignant obstructive jaundice is a prevalent and severe clinical condition, with endoscopic retrograde cholangiopancreatography (ERCP) serving as a crucial treatment modality. Despite its high success rate, the incidence of postoperative complications remains notably high. This review summarizes the potential complications and associated risk factors that patients with malignant obstructive jaundice may encounter following ERCP, and explores their mechanisms and management strategies. The aim is to provide clinicians with risk assessment and management strategies for ERCP in patients with malignant obstructive jaundice, thereby improving postoperative outcomes and reducing the occurrence of complications.

References

[1]  俞毅君, 王毓璈, 徐德征. 内毒素血症和高胆红素血症对外科梗阻性黄疸患者的毒性作用[J]. 中国综合临床, 2001, 17(5): 63-64.
[2]  Hristov, B., Doykov, D., Andonov, V., Doykov, M., Kraev, K., Uchikov, P., et al. (2024) Interventional Treatment of Malignant Biliary Obstruction: Is It Time to Change the Paradigm? Gastroenterology Insights, 15, 266-284.
https://doi.org/10.3390/gastroent15020020
[3]  van den Bosch, R., van der Schelling, G.P., Klinkenbijl, J.H.G., Mulder, P.G.H., van Blankenstein, M. and Jeekel, J. (1994) Guidelines for the Application of Surgery and Endoprostheses in the Palliation of Obstructive Jaundice in Advanced Cancer of the Pancreas. Annals of Surgery, 219, 18-24.
https://doi.org/10.1097/00000658-199401000-00004
[4]  朱晓丹, 陈卫刚, 韩岩智, 等. 恶性梗阻性黄疸不同姑息治疗方法疗效观察[J]. 中国内镜杂志, 2015, 21(4): 371-374.
[5]  陈智慧, 杨红春, 彭勇. ERCP三种引流方式对恶性胆道梗阻的疗效分析[J]. 现代消化及介入诊疗, 2022, 27(1): 87-90.
[6]  Addley, J. and Mitchell, R.M. (2012) Advances in the Investigation of Obstructive Jaundice. Current Gastroenterology Reports, 14, 511-519.
https://doi.org/10.1007/s11894-012-0285-1
[7]  Cahyadi, O., Tehami, N., de-Madaria, E. and Siau, K. (2022) Post-ERCP Pancreatitis: Prevention, Diagnosis and Management. Medicina, 58, Article 1261.
https://doi.org/10.3390/medicina58091261
[8]  Elmunzer, B.J. (2017) Reducing the Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Digestive Endoscopy, 29, 749-757.
https://doi.org/10.1111/den.12908
[9]  Pekgöz, M. (2019) Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review for Prevention and Treatment. World Journal of Gastroenterology, 25, 4019-4042.
https://doi.org/10.3748/wjg.v25.i29.4019
[10]  Jang, S., Stevens, T., Parsi, M.A., Bhatt, A., Kichler, A. and Vargo, J.J. (2022) Superiority of Self-Expandable Metallic Stents over Plastic Stents in Treatment of Malignant Distal Biliary Strictures. Clinical Gastroenterology and Hepatology, 20, e182-e195.
https://doi.org/10.1016/j.cgh.2020.12.020
[11]  Li, J., Li, T., Sun, P., Yu, Q., Wang, K., Chang, W., et al. (2016) Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis. PLOS ONE, 11, e0149066.
https://doi.org/10.1371/journal.pone.0149066
[12]  Parekh, P.J., Majithia, R., Sikka, S.K. and Baron, T.H. (2017) The “Scope” of Post-ERCP Pancreatitis. Mayo Clinic Proceedings, 92, 434-448.
https://doi.org/10.1016/j.mayocp.2016.10.028
[13]  马亚运, 丁左缨, 卢晓平, 等. 内镜逆行胰胆管造影术后胰腺炎风险预测模型的构建及验证[J]. 中国内镜杂志, 2023, 29(12): 65-71.
[14]  Leerhøy, B. and Elmunzer, B.J. (2018) How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Gastrointestinal Endoscopy Clinics of North America, 28, 439-454.
https://doi.org/10.1016/j.giec.2018.05.007
[15]  庄乐怡, 李戟玭, 张文凯, 等. 恶性梗阻性黄疸介入治疗后胆道感染的研究进展[J]. 实用临床医药杂志, 2022, 26(22): 128-131+138.
[16]  胡钢, 钱小星, 杨仁保. ERCP术后发生胆道感染的危险因素[J]. 肝胆外科杂志, 2015, 23(1): 29-31.
[17]  马勇新, 张旭升, 柳科军, 等. 恶性胆道梗阻ERCP术后早期胆道感染预测模型的建立与评价[J]. 中国普通外科杂志, 2023, 32(8): 1208-1217.
[18]  姚晓群, 武勋. ERCP术后胆道感染危险因素及ENBD预防效果[J]. 中华医院感染学杂志, 2021, 31(24): 3757-3761.
[19]  凌玲, 胡久叶, 杜晓莉, 等. 梗阻性黄疸患者经内镜逆行胰胆管造影术后胆道感染的病原菌分布、耐药性及影响因素分析[J]. 现代生物医学进展, 2020, 20(5): 966-970+991.
[20]  Yilmaz, H. and Koçyiğit, B. (2022) Predictors of Postendoscopic Retrograde Cholangiopancreatography Associated Cholangitis: A Retrospective Cohort Study. Turkish Journal of Medical Sciences, 52, 105-112.
https://doi.org/10.3906/sag-2109-84
[21]  陆霁, 蔡建珊, 孙强, 等. 良恶性梗阻性黄疸患者胆道感染的危险因素分析[J]. 上海医药, 2018, 39(13): 27-30+40.
[22]  Xia, M., Wang, S., Wu, J., Gao, D., Ye, X., Wang, T., et al. (2019) The Risk of Acute Cholangitis after Endoscopic Stenting for Malignant Hilar Strictures: A Large Comprehensive Study. Journal of Gastroenterology and Hepatology, 35, 1150-1157.
https://doi.org/10.1111/jgh.14954
[23]  Takinami, M., Murohisa, G., Yoshizawa, Y., Shimizu, E. and Nagasawa, M. (2020) Risk Factors for Cholecystitis after Stent Placement in Patients with Distal Malignant Biliary Obstruction. Journal of Hepato-Biliary-Pancreatic Sciences, 27, 470-476.
https://doi.org/10.1002/jhbp.767
[24]  Watanabe, M., Okuwaki, K., Woo, J., Kida, M., Imaizumi, H., Iwai, T., et al. (2021) Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions. Clinical Endoscopy, 54, 589-595.
https://doi.org/10.5946/ce.2020.136
[25]  Johnson, K.D., Perisetti, A., Tharian, B., Thandassery, R., Jamidar, P., Goyal, H., et al. (2019) Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review. Digestive Diseases and Sciences, 65, 361-375.
https://doi.org/10.1007/s10620-019-05970-3
[26]  杨淮丽, 袁苑, 张宗敏. ERCP术后发生胆道感染的危险因素分析[J]. 肝胆外科杂志, 2019, 27(4): 302-304.
[27]  黄任祥. ERCP术后并发消化道穿孔发生率及危险因素的Meta分析与系统评价[J]. 中西医结合心血管病电子杂志, 2019, 7(7): 176-183.
[28]  叶晓玲, 张宇, 邓涛. 内镜逆行胰胆管造影术穿孔并发症的诊断和管理进展[J]. 疑难病杂志, 2020, 19(6): 627-631.
[29]  郎琳, 吴瑜. 经内镜逆行胰胆管造影术后并发上消化道穿孔及其防治[J]. 中国中西医结合外科杂志, 2021, 27(3): 525-527.
[30]  李谦益, 李能平. 内镜逆行胰胆管造影发生术后并发症的防治进展[J]. 外科理论与实践, 2020, 25(4): 344-348.
[31]  窦磊, 苗春木, 刘长安. ERCP相关并发症治疗进展[J]. 现代医药卫生, 2021, 37(4): 606-609.
[32]  张珊旗, 陈晨, 吴李珠, 等. ERCP术后相关并发症防治研究进展[J]. 牡丹江医学院报, 2021, 42(3): 122-124.
[33]  唐亚红. 内镜逆行胰胆管造影术后出血的高危因素及对策分析[J]. 检验医学与临床, 2021, 18(16): 2414-2417.
[34]  吴晓平. 经内镜逆行胰胆管造影术后胆道出血的临床特征及高危因素分析[J]. 现代实用医学, 2021, 33(5): 683-685.
[35]  Talukdar, R. (2016) Complications of ERCP. Best Practice & Research Clinical Gastroenterology, 30, 793-805.
https://doi.org/10.1016/j.bpg.2016.10.007
[36]  刘天锡, 方登华, 关斌颖, 等. 胆道出血的原因诊断与治疗[J]. 肝胆外科杂志, 2014, 22(4): 286-289.
[37]  王群茹, 张勇, 牟东, 等. 治疗性经内镜逆行胰胆管造影术后胆道出血与原发疾病的关系[J]. 临床肝胆病杂志, 2017, 33(5): 896-898.
[38]  Bae, S.S., Lee, D.W., Han, J. and Kim, H.G. (2019) Risk Factor of Bleeding after Endoscopic Sphincterotomy in Average Risk Patients. Surgical Endoscopy, 33, 3334-3340.
https://doi.org/10.1007/s00464-018-06623-8
[39]  范玲, 傅燕, 刘懿, 等. 内镜逆行胰胆管造影术后出血的研究进展[J]. 临床肝胆病杂志, 2023, 39(10): 2497-2505.
[40]  郭明, 李宁, 吴加国, 等. ERCP术后迟发性出血的危险因素及治疗措施[J]. 浙江实用医学, 2021, 26(2): 127-129+136.
[41]  Veitch, A.M., Radaelli, F., Alikhan, R., Dumonceau, J.M., Eaton, D., Jerrome, J., et al. (2021) Endoscopy in Patients on Antiplatelet or Anticoagulant Therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) Guideline Update. Gut, 70, 1611-1628.
https://doi.org/10.1136/gutjnl-2021-325184
[42]  杨雪丽, 邓涛. 内镜逆行性胰胆管造影相关并发症及其防治措施的研究进展[J]. 胃肠病学和肝病学杂志, 2016, 25(11): 1326-1330.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133